| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 10/19/2006 | WO2006110884A2 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists |
| 10/19/2006 | WO2006110816A2 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors |
| 10/19/2006 | WO2006110683A1 2-substituted-1h-benzimidazole-4-carboxamides are parp inhibitors |
| 10/19/2006 | WO2006109933A1 Antifungal triazole derivatives |
| 10/19/2006 | WO2006109846A1 Triazole derivative and the use thereof |
| 10/19/2006 | WO2006109836A1 Crystal of aminopyrrolidine derivative and prodcution method thereof |
| 10/19/2006 | WO2006109762A1 Novel process for producing ramosetron or its salt |
| 10/19/2006 | WO2006108800A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 10/19/2006 | WO2006108791A2 Heterocyclylethylheterocyclylcarboxamide derivatives as fungicides |
| 10/19/2006 | WO2006108711A1 Substituted chroman derivatives, method for the production and the use thereof in the form of antiphlogistics |
| 10/19/2006 | WO2006108701A1 3- (1,2,4-triazol-3ylalkyl) azabriclo (3.1.0) hexane derivatives as modulators of dopamine d3 receptors |
| 10/19/2006 | WO2006108700A1 3-triazolylthioalkyl-3-azabicyclo (3 - 1 - o) hexanes and their use as dopamine d3 receptor ligands |
| 10/19/2006 | WO2006108640A1 Phenylacetamides suitable as protein kinase inhibitors |
| 10/19/2006 | WO2006108591A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 10/19/2006 | WO2006108487A1 (lh-ind0l-7-yl)-( (pyrimidin-2 -yl-amino) methanone derivatives and related compounds as igf-rl inhibitors for treating cancer |
| 10/19/2006 | WO2006082598A3 Novel crystalline forms of rizatriptan benzoate |
| 10/19/2006 | WO2006081230A3 3-(indazol-5-yl)-(1,2, 4) triazine derivatives and related compounds as protein kinase inhibitors for the treatment of cancer |
| 10/19/2006 | WO2006050964A3 Indinavir derivatives useful in immunoassay |
| 10/19/2006 | WO2006050476A3 Pyrimidine derivatives as ion channel modulators and methods of use |
| 10/19/2006 | US20060235226 Synthesis of diketopiperazines |
| 10/19/2006 | US20060235222 Indole-derivative modulators of steroid hormone nuclear receptors |
| 10/19/2006 | US20060235069 Benzamide modulators of metabotropic glutamate receptors |
| 10/19/2006 | US20060235055 Therapeutic agents useful for treating pain |
| 10/19/2006 | US20060235054 e.g. 3-substituted 5-(4-fluorophenyl)-4-(4-pyridyl)imidazole-2-thione; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent |
| 10/19/2006 | US20060235051 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide; viricide; with other active agents: interferons, ribavirin, immunoglobulins, immunomodulators, anti-inflammatory agents, antibiotics, antivirals or anti-infectious |
| 10/19/2006 | US20060235037 Heterocyclic inhibitors of protein arginine methyl transferases |
| 10/19/2006 | US20060235036 Vanilloid receptor ligands and their use in treatments |
| 10/19/2006 | US20060235026 Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists |
| 10/19/2006 | US20060235022 Therapeutic agents useful for treating pain |
| 10/19/2006 | US20060235021 Phenylpyridazine derivatives as ligands for gaba receptors |
| 10/19/2006 | US20060235019 Substituted quinazolinone compounds |
| 10/19/2006 | US20060235018 Prokineticin 1 receptor antagonists |
| 10/19/2006 | US20060235017 e.g. 1-Methyl-7-(pyrimidin-4-yloxy)-1H-indole-2-carboxylic acid (5-tert-butyl-3-methanesulfonylamino-2-methoxy-phenyl)-amide; antiinflammatory, antidiabetic, analgesic agent; osteoarthritis, atherosclerosis, contact dermatitis, bone resorption diseases, reperfusion injury, asthma |
| 10/19/2006 | US20060235015 Pyrrole-2,5-dione derivatives as liver x receptor modulators |
| 10/19/2006 | US20060235007 Substituted 1,4-diazepines and uses thereof |
| 10/19/2006 | US20060235004 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands |
| 10/19/2006 | US20060235000 Compositions and methods for reducing the risk of epileptic occurrence and/or for treatment of seizure disorders |
| 10/19/2006 | US20060234984 Mitotic kinesin inhibitors |
| 10/19/2006 | US20060234927 Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| 10/19/2006 | US20060234865 Using an acylurea compound containing pyrimidine ring;; used before the harvest of crops such as potato, sunflower, soybean, rape, sorghum and the like; methyl [2-{2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-1,2,3,6-tetrahydropyrimidin-1-yl]phenoxy}phenoxy]acetate |
| 10/19/2006 | DE112004001502T5 Neurobeschützende und Anti-Proliferationsverbindungen Neurobeschützende and anti-proliferative compounds |
| 10/19/2006 | CA2608078A1 Crystal of aminopyrrolidine derivative and prodcution method thereof |
| 10/19/2006 | CA2604895A1 (1h-indol-7-yl)-( (pyrimidin-2-ylamino) methanone derivatives and related compounds as igf-r1 inhibitors for the treatment of cancer |
| 10/19/2006 | CA2604822A1 Novel process for producing ramosetron or its salt |
| 10/19/2006 | CA2604516A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 10/19/2006 | CA2603941A1 Phenylacetamides suitable as protein kinase inhibitors |
| 10/19/2006 | CA2601986A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 10/19/2006 | CA2598207A1 Substituted chroman derivatives, method for the production and the use thereof in the form of antiphlogistics |
| 10/18/2006 | EP1712550A2 Substituted triazole diamine derivatives as kinase inhibitors |
| 10/18/2006 | EP1712548A2 5-amino-4-hydroxy-7-(pyridinylmethyl)-alkanamide derivatives and related compounds as renin inhibitors for the treatment of hypertension |
| 10/18/2006 | EP1711825A2 Conjugated small molecules |
| 10/18/2006 | EP1711617A1 Method and compositions for identifying anti-hiv therapeutics compounds |
| 10/18/2006 | EP1711488A1 Heterocyclic modulators of the glucocorticoid receptor, ap-1, and/or nf-kappa b activity and use thereof |
| 10/18/2006 | EP1711487A1 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 10/18/2006 | EP1711486A2 Bis-indole pyrroles useful as antimicrobials agents |
| 10/18/2006 | EP1711474A1 5-phenypyridines and their use as microbicides |
| 10/18/2006 | EP1711473A1 Substituted n-cyclohexylimidazolinones having an mch-modulatory effect |
| 10/18/2006 | EP1711184A1 (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity |
| 10/18/2006 | EP1711175A1 Diurea derivatives |
| 10/18/2006 | EP1107957B1 Pyrimidine compounds |
| 10/18/2006 | CN1849321A Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
| 10/18/2006 | CN1849318A Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds |
| 10/18/2006 | CN1849306A Matrix metalloproteinase inhibitors |
| 10/18/2006 | CN1849302A 1, 3-disubstituted azetidine derivatives for use as CCR-3 receptor antagonists in the treatment of inflammatory and allergic diseases |
| 10/18/2006 | CN1849121A Piperazine derivatives as bradyknin antagonist |
| 10/18/2006 | CN1849117A Entry inhibitors of the HIV virus |
| 10/18/2006 | CN1847243A Prepn process and prepn of new soluble voriconazole salt |
| 10/18/2006 | CN1847242A Novel process for producing ramosetron or its salt |
| 10/18/2006 | CN1847201A Amino group-containing chiral ionic liquid and its prepn process and application |
| 10/18/2006 | CN1846697A New use of angiotensin ii antagonists |
| 10/18/2006 | CN1280288C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 10/18/2006 | CN1280278C Method for producing asymmetrical 4,6-bis (aryloxy) pyrimidine derivatives |
| 10/18/2006 | CN1280277C Diamide invertebrate pest control agents contg. non-aromatic heterocyclic ring |
| 10/18/2006 | CN1280269C Aliphatic nitrogenous five-membered ring compounds |
| 10/18/2006 | CN1280267C Sulfonylaminocarboxylic acids |
| 10/18/2006 | CN1279818C Herbicidal synergistic composition, and method of controlling weeds |
| 10/17/2006 | US7122680 3-Substituted oxindole β3 agonsists |
| 10/17/2006 | US7122677 NK1 antagonists |
| 10/17/2006 | US7122675 Gamma secretase inhibitors |
| 10/17/2006 | US7122674 Process for preparing high-purity hydroxyindolylglyoxylamides |
| 10/17/2006 | US7122672 N-alkynyl-2-quinolin-(isoquinolin- and quinazolin-)oxyalkylamides; treating agricultural and horticultural fungal infections of plants |
| 10/17/2006 | US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc |
| 10/17/2006 | US7122557 5-chloro-N-(5-chloropyridin-2-yl)-2-[(4-{(Z)-(dimethylamino)[(methylsulfonyl)imino]methyl}benzoyl)amino]benzamide; treating thromboembolic disorders, optionally with other active agents |
| 10/17/2006 | US7122552 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction |
| 10/17/2006 | US7122551 Metalloproteinase inhibitor compounds |
| 10/17/2006 | US7122550 Protein kinase inhibitors |
| 10/17/2006 | US7122547 Anthranilic acid amides and the use thereof as medicaments |
| 10/17/2006 | US7122546 GABAA (gamma-aminobutyric acid) receptor modulators; anxiolytic, antidepresant agents; attention deficit disorder, Alzheimer*s disease treatment; central nervous systmem disorders |
| 10/17/2006 | US7122544 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
| 10/17/2006 | US7122542 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 10/17/2006 | US7122539 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications. |
| 10/17/2006 | CA2395705C Substituted phenyl-piperazine derivatives, their preparation and use |
| 10/17/2006 | CA2339661C Use of derivatives of aryl(or heteroaryl)azolylcarbinols in the manufacture of a medicament for the treatment of disorders mediated by an excess of substance p |
| 10/17/2006 | CA2260065C Process for preparing 1-substituted 4-cyano-1,2,3-triazoles |
| 10/17/2006 | CA2238818C 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists |
| 10/17/2006 | CA2226669C Herbicidal sulphonylamino(thio)carbonyl compounds |
| 10/12/2006 | WO2006108107A1 Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors |
| 10/12/2006 | WO2006108039A2 Substituted azetidinones |
| 10/12/2006 | WO2006106812A1 Propane-1,3-dion derivative or salt thereof |
| 10/12/2006 | WO2006106425A1 Bicyclic [3.1.0] heteroaryl amides as type i glycine transport inhibitors |